Ferro-Alloy Resources Limited (LON:FAR), the vanadium producer and developer of the large Balasausqandiq vanadium deposit in Southern Kazakhstan, has announced…
Read More
Hippocratic AI raises $126M, hits $3.5 billion valuation
Hippocratic AI, a leading developer of safety-driven generative AI solutions for healthcare, has raised $126 million in its Series C…
Read More
Greg Goodman warns of risks in data centre funding boom
Industrial property giant Goodman has dramatically ramped up its ambition to build data centres, forecasting they will account for three-quarters…
Read More
Orchid Island Capital (ORC): Reassessing Valuation After Major Equity Raise and Strategic Capital Shift
Orchid Island Capital announced a $500 million follow-on equity offering and an $80 million shelf registration. These relocates highlight its…
Read More
Deloitte Middle East Launches Human Capital Trfinishs 2025 Report: Navigating Work in the Age of AI, Agility, and Human Sustainability
Deloitte Middle East has launched its Human Capital Trfinishs Report 2025, unveiling eight timely studies that examine the evolving relationship…
Read More
Capital-raising: The Initiates holds signing ceremony, fact behind the combined offer
Sam Ndata, Doyen, Ivie Dima-Okoji, Team Lead, Primary Market NGX, Reuben Ossai, MD, The Initiates Plc, Jude Chiemeka, CEO, NGX,…
Read MoreEuropean tech startup funding to fall to $45 billion in 2023 -Atomico | WTAQ News Talk | 97.5 FM · 1360 AM
By Supantha Mukherjee STOCKHOLM (Reuters) – Total capital invested into European tech startups is projected to fall to $45 billion…
Read More
Subros’ (NSE:SUBROS) five-year total shareholder returns outpace the underlying earnings growth
The worst result, after purchaseing shares in a company (assuming no leverage), would be if you lose all the money…
Read More
Greenvale Energy Ltd Suspfinishs Trading Amid Capital Raising Efforts
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert…
Read More
Why Nurix Therapeutics (NRIX) Is Up 5.3% After Advancing Bexobrutideg Trial and Raising $250 Million
Nurix Therapeutics announced the initiation of its pivotal DAYBreak Phase 2 clinical trial evaluating bexobrutideg for relapsed or refractory chronic…
Read More
